Difference between revisions of "Callon2016"

From emcawiki
Jump to: navigation, search
(Created page with "{{BibEntry |BibType=ARTICLE |Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach |Title=Which Clinicia...")
 
m (AndreiKorbut moved page Callon2015 to Callon2016 without leaving a redirect)
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
 
|BibType=ARTICLE
 
|BibType=ARTICLE
 
|Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach
 
|Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach
|Title=Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?
+
|Title=Which clinician questions elicit accurate disclosure of antiretroviral non-adherence when talking to patients?
|Tag(s)=EMCA; AIDS; medication; Adherence; Physician-Patient Relations; Counseling; Medical;  
+
|Tag(s)=EMCA; AIDS; medication; Adherence; Physician-Patient Relations; Counseling; Medical;
|Key=Callon2015
+
|Key=Callon2016
|Year=2015
+
|Year=2016
 +
|Language=English
 
|Journal=AIDS and Behavior
 
|Journal=AIDS and Behavior
 +
|Volume=20
 +
|Number=5
 +
|Pages=1108–1115
 
|URL=http://link.springer.com/article/10.1007/s10461-015-1231-7
 
|URL=http://link.springer.com/article/10.1007/s10461-015-1231-7
 
|DOI=10.1007/s10461-015-1231-7
 
|DOI=10.1007/s10461-015-1231-7
 
|Abstract=This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.
 
|Abstract=This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.
 
 
}}
 
}}

Latest revision as of 10:40, 16 December 2019

Callon2016
BibType ARTICLE
Key Callon2016
Author(s) Wynne Callon, Somnath Saha, P. Todd Korthuis, Ira B. Wilson, Richard D. Moore, Jonathan Cohn, Mary Catherine Beach
Title Which clinician questions elicit accurate disclosure of antiretroviral non-adherence when talking to patients?
Editor(s)
Tag(s) EMCA, AIDS, medication, Adherence, Physician-Patient Relations, Counseling, Medical
Publisher
Year 2016
Language English
City
Month
Journal AIDS and Behavior
Volume 20
Number 5
Pages 1108–1115
URL Link
DOI 10.1007/s10461-015-1231-7
ISBN
Organization
Institution
School
Type
Edition
Series
Howpublished
Book title
Chapter

Download BibTex

Abstract

This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.

Notes